<DOC>
	<DOC>NCT02030275</DOC>
	<brief_summary>The purpose of this study is to determine the effectiveness of RXI-109 in reducing the recurrence of hypertrophic scar formation following elective revision of a pre-existing hypertrophic abdominal scar.</brief_summary>
	<brief_title>A Study to Evaluate the Effectiveness and Safety of RXI 109 on the Outcome of Scar Revision Surgery in Healthy Adults</brief_title>
	<detailed_description />
	<mesh_term>Hypertrophy</mesh_term>
	<mesh_term>Cicatrix, Hypertrophic</mesh_term>
	<criteria>Adults, 2155 years of age in general good health Previous partial hysterectomy, Cesarean section or abdominoplasty surgery resulting in a transverse hypertrophic scar of â‰¥ 11 cm in length Scar to be revised must have been present for &gt; 9 months Use of tobacco or nicotinecontaining products Pregnant or lactating Postmenopausal or full hysterectomy</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Hypertrophic scar</keyword>
	<keyword>Cicatrix</keyword>
	<keyword>Scar prevention</keyword>
	<keyword>Scar revision</keyword>
</DOC>